Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IgG Glycosylation Analysis in Patients with Ring14 Syndrome Unveils Novel Pathomechanisms and New Therapy Perspectives.

Biomolecules·2026
Same author

A splice-altering intronic variant in two multiplex families refines autosomal recessive COG4-related congenital disorder of glycosylation.

Molecular genetics and metabolism·2026
Same author

Lipooligosaccharide architecture in Acinetobacter modestus CM11G: a non-pathogenic strain.

Carbohydrate research·2025
Same author

The Other Side of the Same Coin: Beyond the Coding Region in Amyotrophic Lateral Sclerosis.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Tracking additives fate from a biodegradable mulch film to soil: a comprehensive LC-MS investigation.

Journal of hazardous materials·2025
Same author

Mono-allelic p.R37H Dehydrodolichyl Diphosphate Synthase variants lead to protein glycosylation defects, aberrant lipid profiles and interneuron scarcity in a novel mouse model of progressive epileptic encephalopathy.

bioRxiv : the preprint server for biology·2025
Same journal

Nanotechnology-Stem Cell Strategies in 3D Glioblastoma Organoid: Targeting Glioma Stem Cells Within a Complex Tumor Microenvironment.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Mapping the 3D Chromosome Organization of a Biosynthetic Gene Cluster by Capture Hi-C (CHi-C).

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Mapping the 3D Chromosome Organization of Streptomyces by Hi-C.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

CUT&Tag Epigenomic Profiling of Biosynthetic Gene Clusters in Arabidopsis thaliana.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Rhizobium rhizogenes-Mediated Hairy Root Transformation Protocol for Lotus japonicus and Other Legumes.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Characterization of Bioactive Saponins from Sea Cucumbers.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Jul 1, 2025

Mass Spectrometric Analysis of Glycosphingolipid Antigens
13:09

Mass Spectrometric Analysis of Glycosphingolipid Antigens

Published on: April 16, 2013

16.6K

CSF N-Glycomics Using MALDI MS Techniques.

Angela Messina1, Donata Agata Romeo1, Rita Barone1,2

  • 1CNR, Istituto per i Polimeri, Compositi e i Biomateriali Catania, Catania, Italy.

Methods in Molecular Biology (Clifton, N.J.)
|March 1, 2024
PubMed
Summary
This summary is machine-generated.

This study details a method for analyzing cerebrospinal fluid N-glycans, crucial for understanding Alzheimer's disease (AD). The optimized technique successfully linked specific N-glycan profiles to different AD stages.

Keywords:
ADCSFMALDI MSMCIN-glycans

More Related Videos

Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments
10:59

Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments

Published on: February 7, 2025

997
Improved In-gel Reductive β-Elimination for Comprehensive O-linked and Sulfo-glycomics by Mass Spectrometry
13:06

Improved In-gel Reductive β-Elimination for Comprehensive O-linked and Sulfo-glycomics by Mass Spectrometry

Published on: November 20, 2014

11.9K

Related Experiment Videos

Last Updated: Jul 1, 2025

Mass Spectrometric Analysis of Glycosphingolipid Antigens
13:09

Mass Spectrometric Analysis of Glycosphingolipid Antigens

Published on: April 16, 2013

16.6K
Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments
10:59

Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments

Published on: February 7, 2025

997
Improved In-gel Reductive β-Elimination for Comprehensive O-linked and Sulfo-glycomics by Mass Spectrometry
13:06

Improved In-gel Reductive β-Elimination for Comprehensive O-linked and Sulfo-glycomics by Mass Spectrometry

Published on: November 20, 2014

11.9K

Area of Science:

  • Biochemistry
  • Analytical Chemistry
  • Neuroscience

Background:

  • Cerebrospinal fluid (CSF) N-glycans offer insights into neurological conditions.
  • Structural elucidation of N-glycans is vital for understanding their role in diseases like Alzheimer's disease (AD).

Purpose of the Study:

  • To present a robust methodology for the structural elucidation of the CSF N-glycome.
  • To optimize N-glycan analysis for high-quality mass spectrometry data.
  • To apply the developed method for identifying N-glycan profiles associated with Alzheimer's disease.

Main Methods:

  • N-glycans were released from glycoproteins using peptide-N-glycosidase F (PNGase F).
  • Purification involved C18 Sep-Pak and porous graphitized carbon (PGC) solid phase extraction (SPE).
  • Permethylation enhanced mass spectrometry sensitivity, followed by MALDI TOF MS and MS/MS analysis for molecular assignments.

Main Results:

  • Optimized methodology yields high-quality mass spectra with excellent signal-to-noise ratios up to m/z 4800.
  • The method successfully distinguished N-glycome profiles between early and advanced stages of Alzheimer's disease.

Conclusions:

  • The presented methodology provides a reliable approach for CSF N-glycome structural elucidation.
  • This technique is valuable for biomarker discovery in Alzheimer's disease and other neurological disorders.